These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors. Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
4. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting. Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313 [TBL] [Abstract][Full Text] [Related]
5. Clinical and biochemical aspirin resistance in patients with recurrent cerebral ischemia. El-Mitwalli A; Azzam H; Abu-Hegazy M; Gomaa M; Wasel Y Clin Neurol Neurosurg; 2013 Jul; 115(7):944-7. PubMed ID: 23069275 [TBL] [Abstract][Full Text] [Related]
6. Optical platelet aggregometry does not appear useful as a means of assessing the risk of recurrent vascular events in aspirin-treated patients. Sztriha LK; Sas K; Seres E; Boda K; Lenti L; Csifcsak G; Kovacs N; Vecsei L Acta Neurol Scand; 2008 Apr; 117(4):250-4. PubMed ID: 17961197 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry. Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512 [TBL] [Abstract][Full Text] [Related]
9. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin. Abumiya T; Houkin K J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093 [TBL] [Abstract][Full Text] [Related]
10. Variable platelet response to aspirin in patients with ischemic stroke. Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543 [TBL] [Abstract][Full Text] [Related]
11. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. Grundmann K; Jaschonek K; Kleine B; Dichgans J; Topka H J Neurol; 2003 Jan; 250(1):63-6. PubMed ID: 12527994 [TBL] [Abstract][Full Text] [Related]
12. The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy. Cervera A; Tàssies D; Obach V; Amaro S; Reverter JC; Chamorro A Cerebrovasc Dis; 2007; 24(2-3):242-6. PubMed ID: 17630485 [TBL] [Abstract][Full Text] [Related]
13. Can aspirin resistance be clinically predicted in stroke patients? Seok JI; Joo IS; Yoon JH; Choi YJ; Lee PH; Huh K; Bang OY Clin Neurol Neurosurg; 2008 Feb; 110(2):110-6. PubMed ID: 17964711 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144 [TBL] [Abstract][Full Text] [Related]
15. Aspirin resistance in patients with chronic renal failure. Tanrikulu AM; Ozben B; Koc M; Papila-Topal N; Ozben T; Caymaz O J Nephrol; 2011; 24(5):636-46. PubMed ID: 21279952 [TBL] [Abstract][Full Text] [Related]
16. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183 [TBL] [Abstract][Full Text] [Related]